Hoya’s Pentax Medical to Open Manufacturing, R&D, Service Center in China

Pentax Medical, a division of Hoya Group, today announced the establishment of a manufacturing, research and development, and service center in Shanghai, China. The facility will focus on the company’s endoscopic products and services and be dedicated to the China market under Pentax Medical Shanghai.

The China facility will add to already established R&D centers in Japan, United States, and Germany as the company strives to “enhance customer experience” through customer care and quickly resolving inquiries. The additional facility will, according to the company, allow for closer interaction between stakeholders and R&D.

“We have already established R&D center in Japan, US and Germany to take customers' voices into our R&D activities,” said Rainer Burkard, global president, Pentax, and company president – medtech and life science company, Hoya Corporation, in a press release announcing the facility. “This establishment will allow and cater for closer interaction with the clinical stakeholders and our R&D in China as well."

Additionally, Pentax will be contributing to the country’s “Healthy China” initiative by locally manufacturing high tech medical devices.

"This is a great milestone in Pentax Medical history to add a substantial local facility in China to produce, deliver, and repair innovative endoscopic solutions for medical institutions in China,” said Maha Guruswamy, president, Pentax Asia Pacific region. “This will speed up delivery of Pentax Medical's innovative endoscopic solutions to support enhancement of quality of care in China more than ever.”

Currently, there is no word on a specific site location for the new facility, a timeframe in which it will be built, the projected construction costs, and miscellaneous costs associated to the build.